Table 1.
Characteristics | N (%) | No. of CR/all patients | CR rate, % (95% CI) | P value |
---|---|---|---|---|
Age (years) | ||||
Median (range) | 65 (35‐85) | |||
64≥ | 46 (47) | 37/46 | 80 (66.1‐95.2) | 0.135 |
65≤ | 51 (53) | 47/51 | 92 (81.1‐87.8) | |
Sex | ||||
Male | 47 (48) | 41/47 | 87 (74.3‐95.2) | 1.000 |
Female | 50 (52) | 43/50 | 86 (73.3‐94.2) | |
Clinical stage | ||||
I | 95 (98) | 83/95 | 87 (78.9‐93.3) | 0.251 |
II1 | 2 (2) | 1/2 | 50 (1.3‐98.7) | |
Histological scorea | ||||
Grade 4 | 32 (33) | 26/32 | 81 (63.6‐92.8) | 0.345 |
Grade 5 | 65 (67) | 58/65 | 89 (79.1‐95.6) | |
Dominant site of lesiona | ||||
Proximal third (U) | 40 (41) | 34/40 | 85 (70.2‐94.3) | NE |
Middle third (M) | 76 (78) | 65/76 | 86 (75.6‐92.6) | |
Distal third (L) | 20 (21) | 17/20 | 85 (62.1‐96.8) | |
Endoscopic type | ||||
Superficial | 89 (92) | 79/89 | 89 (80.3‐94.5) | 0.016 |
Ulcerative | 7 (7) | 5/7 | 71 (29.0‐96.3) | |
Elevated | 1 (1) | 0/1 | 0 (0.0‐97.5) | |
Depth by EUS | ||||
Mucosa | 27 (28) | 24/27 | 89 (70.8‐97.7) | 0.597 |
Submucosa or deeper | 10 (10) | 8/10 | 80 (44.4‐97.5) | |
t(11;18)/API2‐MALT1 (n = 73) | ||||
Positive | 1 (1) | 1/1 | 100 (2.5‐100.0) | 1.000 |
Negative | 72 (99) | 63/72 | 88 (77.6‐94.1) |
CR, complete remission; NE, not evaluated, CI, confidence interval.
Wotherspoon's score.
Major site.